Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ImmunoPET Imaging With ZED88082A in Patients Before and During Treatment With 1) MPDL3280A or 2) PD-1 Antibody Plus or Minus Ipilimumab

NCT04029181 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04029181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04029181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ImmunoPET Imaging With ZED88082A in Patients Before and During Treatment With 1) MPDL3280A or 2) PD-1 Antibody Plus or Minus Ipilimumab
Lead sponsor
University Medical Center Groningen
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 14, 2019
Completion date
December 31, 2024
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, unresectable malignant neoplasm